RA Capital Management, L.P. 13D and 13G filings for Aclaris Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-08-14 4:36 pm Purchase | 2026-06-30 | 13G | ACLARIS THERAPEUTICS INC ACRS | RA Capital Management, L.P. | 12,723,026 9.100% | 5,096,321 (+66.82%) | Filing |
| 2026-04-07 5:59 pm Purchase | 2026-03-31 | 13G | ACLARIS THERAPEUTICS INC ACRS | RA Capital Management, L.P. | 7,626,705 6.300% | 7,626,705 (New Position) | Filing |
| 2024-02-14 5:01 pm Sale | 2023-12-31 | 13G | ACLARIS THERAPEUTICS INC ACRS | RA Capital Management, L.P. | 0 0.000% | -4,398,453 (Position Closed) | Filing |
| 2022-04-25 4:30 pm Purchase | 2022-04-13 | 13G | ACLARIS THERAPEUTICS INC ACRS | RA Capital Management, L.P. | 4,398,453 7.100% | 4,398,453 (New Position) | Filing |